Home/Filings/4/0001104659-17-047846
4//SEC Filing

Charles Scott J 4

Accession 0001104659-17-047846

CIK 0001660719other

Filed

Jul 27, 8:00 PM ET

Accepted

Jul 28, 7:00 PM ET

Size

5.0 KB

Accession

0001104659-17-047846

Insider Transaction Report

Form 4
Period: 2017-07-28
Charles Scott J
Chief Financial Officer
Transactions
  • Sale

    Common Shares, without par value

    2017-07-28$1.25/sh10,804$13,509280,551 total
Footnotes (1)
  • [F1]This represents shares sold by the issuer on behalf of the reporting person pursuant to an instruction made in accordance with Rule 10b5-1 for payment of withholding tax liability incurred upon the vesting of 29,000 restricted stock units, which vested on July 27, 2017. 7,284 of such restricted stock units were previously granted on July 27, 2015 and 21,716 of such restricted stock units were previously granted on February 12, 2016.

Documents

1 file

Issuer

Aralez Pharmaceuticals Inc.

CIK 0001660719

Entity typeother

Related Parties

1
  • filerCIK 0001649483

Filing Metadata

Form type
4
Filed
Jul 27, 8:00 PM ET
Accepted
Jul 28, 7:00 PM ET
Size
5.0 KB